SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan
· Delayed Price · Currency is TWD 19.95
+0.10 (0.50%)
Apr 27, 2026, 2:31 PM CST
TPEX:4192 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 157.33 | 205.49 | 264.7 | 269.15 | 552.97 | Upgrade
|
| Trading Asset Securities | 7.07 | 6.96 | 6.66 | 6.66 | 6.66 | Upgrade
|
| Cash & Short-Term Investments | 164.41 | 212.44 | 271.36 | 275.81 | 559.63 | Upgrade
|
| Cash Growth | -22.61% | -21.71% | -1.61% | -50.72% | 2.52% | Upgrade
|
| Accounts Receivable | 6.14 | 2.37 | 2.7 | 1.91 | 1.81 | Upgrade
|
| Other Receivables | 33.34 | 32.78 | 31.69 | 30.87 | 30.27 | Upgrade
|
| Receivables | 39.48 | 35.15 | 34.4 | 32.78 | 32.08 | Upgrade
|
| Inventory | 9.69 | 10.06 | 3.13 | 36.4 | 114.04 | Upgrade
|
| Prepaid Expenses | 1.45 | 2.39 | 1.46 | 2.71 | 3.73 | Upgrade
|
| Other Current Assets | 0.24 | 0.42 | 0.13 | 0.54 | 1.22 | Upgrade
|
| Total Current Assets | 215.26 | 260.46 | 310.48 | 348.23 | 710.71 | Upgrade
|
| Property, Plant & Equipment | 3.01 | 9.48 | 4.63 | 14.81 | 11.12 | Upgrade
|
| Long-Term Investments | - | 3.91 | 12.08 | 15.09 | 20.36 | Upgrade
|
| Other Intangible Assets | 36.99 | 43.89 | 51.11 | 58.47 | 82.21 | Upgrade
|
| Other Long-Term Assets | 0.45 | 0.06 | 0.06 | 0.04 | 0.04 | Upgrade
|
| Total Assets | 255.7 | 317.8 | 378.36 | 436.65 | 824.44 | Upgrade
|
| Accounts Payable | 1.2 | 9.51 | 0.16 | 0.87 | 0.16 | Upgrade
|
| Accrued Expenses | 3.74 | 3.93 | 16.96 | 114.13 | 252.26 | Upgrade
|
| Short-Term Debt | - | - | - | 60 | 120 | Upgrade
|
| Current Portion of Leases | 1.95 | 6.8 | 1.95 | 10.21 | 5.3 | Upgrade
|
| Current Unearned Revenue | 0.83 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 2.35 | 1.89 | 2.15 | 1.43 | 3.8 | Upgrade
|
| Total Current Liabilities | 10.07 | 22.12 | 21.23 | 186.64 | 381.52 | Upgrade
|
| Long-Term Leases | - | 0.99 | - | 0.99 | - | Upgrade
|
| Total Liabilities | 10.07 | 23.11 | 21.23 | 187.64 | 381.52 | Upgrade
|
| Common Stock | 351.65 | 351.65 | 351.65 | 1,151 | 1,151 | Upgrade
|
| Additional Paid-In Capital | 12.62 | 66.91 | 105.08 | - | 263.5 | Upgrade
|
| Retained Earnings | -82.32 | -54.28 | -38.17 | -843.33 | -918.16 | Upgrade
|
| Comprehensive Income & Other | -36.33 | -69.58 | -61.42 | -58.43 | -53.19 | Upgrade
|
| Shareholders' Equity | 245.63 | 294.69 | 357.14 | 249.01 | 442.92 | Upgrade
|
| Total Liabilities & Equity | 255.7 | 317.8 | 378.36 | 436.65 | 824.44 | Upgrade
|
| Total Debt | 1.95 | 7.79 | 1.95 | 71.2 | 125.3 | Upgrade
|
| Net Cash (Debt) | 162.46 | 204.66 | 269.4 | 204.6 | 434.34 | Upgrade
|
| Net Cash Growth | -20.62% | -24.03% | 31.67% | -52.89% | 36.84% | Upgrade
|
| Net Cash Per Share | 4.62 | 5.82 | 8.40 | 6.65 | 14.31 | Upgrade
|
| Filing Date Shares Outstanding | 35.17 | 35.17 | 35.17 | 30.74 | 30.74 | Upgrade
|
| Total Common Shares Outstanding | 35.17 | 35.17 | 35.17 | 30.74 | 30.74 | Upgrade
|
| Working Capital | 205.19 | 238.34 | 289.26 | 161.59 | 329.19 | Upgrade
|
| Book Value Per Share | 6.99 | 8.38 | 10.16 | 8.10 | 14.41 | Upgrade
|
| Tangible Book Value | 208.64 | 250.79 | 306.03 | 190.54 | 360.71 | Upgrade
|
| Tangible Book Value Per Share | 5.93 | 7.13 | 8.70 | 6.20 | 11.73 | Upgrade
|
| Machinery | 39.64 | 39.41 | 39.2 | 38.78 | 39.53 | Upgrade
|
| Leasehold Improvements | 18.38 | 18.38 | 18.38 | 18.38 | 18.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.